Biotech Attracts Significant Premarket Buying Pressure
2022年9月27日 - 11:10PM
AllPennyStocks.com
A North Carolina-based biotech company is
seeing some premarket action on Tuesday after the company announced
the final results from the Phase 2 VIBRANT study of vurolenatide
in...
To read the full story on AllPennyStocks.com, click
here.
9 Meters Biopharma (NASDAQ:NMTR)
過去 株価チャート
から 5 2024 まで 6 2024
9 Meters Biopharma (NASDAQ:NMTR)
過去 株価チャート
から 6 2023 まで 6 2024